Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,425.00    0.00 (0.00%)
Bid:
5,400.00
Ask:
5,500.00
Spread: 100.00 (1.852%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Directorate Changes

6 Mar 2020 07:00

RNS Number : 2063F
Camellia PLC
06 March 2020
 

6 March 2020

 

Camellia Plc

(the "Company")

 

Directorate Changes

 

Camellia Plc is pleased to announce the following changes to the Board.

 

Appointment of Simon Turner as a non-executive director with effect from 6 March 2020.

 

Simon is President of the board of the trustee of The Camellia Foundation, a Bermudian trust, the income of which is utilised for charitable, educational and humanitarian causes at the discretion of the trustees. Through its subsidiary, The Camellia Foundation controls 51.67 per cent. of the voting rights of Camellia Plc.

 

Appointment of Jonathon Bond as an independent non-executive director with effect from 6 March 2020.

 

Jonathon spent 25 years in the private equity industry with a particular focus on raising standards of governance and performance. He has extensive international and general management experience, having founded and served on the board of several significant businesses including Jupiter Asset Management Plc.

 

Further information, as required pursuant to Schedule 2(g) of the AIM Rules for Companies, is set out below:-

 

Simon Charles Turner, aged 44

 

Current directorships/partnerships

Past directorships/partnerships within the last 5 years

 

The Camellia Foundation (UK)

None

Camellia Holding AG (Switzerland)

 

The Camellia Private Trust Company Ltd (Bermuda)

 

 

Jonathon Roderick Alan Bond, aged 56

 

Current directorships/partnerships

Past directorships/partnerships within the last 5 years

 

Chalke Valley History Festivals Limited

Blu Homes (USA)

CV Schools History Festival Limited

Ecover (UK) Limited

Giles W. Pritchard-Gordon & Co. Limited

Farncombe Estate Holdings Limited

Grosvenor Limited

LM Holdings EF Limited

Grosvenor UK Finance Plc

Method Products Limited

HBOS Investment Fund Managers Limited

Number One Lansdowne Gardens Limited

Institute of Business Ethics

People Against Dirty Holdings Limited

Jupiter Fund Management Plc

People Against Dirty UK Limited

Lloyds Bank General Insurance Holdings Limited

Ruths Hotel (Denmark)

Lloyds Bank General Insurance Limited

Sccl 3 Limited

One54 Holdings Ltd

Sccl 4 Limited

S.J.P. Trust Corporation Limited

Sccl 4 Services Limited

Scottish Widows Financial Services Holdings

Skagen Conscience Capital Limited

Scottish Widows Group Limited

Skagen Property Limited

Scottish Widows Limited

Skagen Ro Limited

Scottish Widows Unit Trust Managers Limited

The Stockwell Partnership Limited

St Andrew's Insurance Plc

The Young Musicians Symphony Orchestra

Standard Life Private Equity Trust Plc

 

 

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Tom Franks, CEO

 

Panmure Gordon & Co (Nominated Adviser and Broker) 020 7886 2500

Emma Earl

Erik Anderson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUVOBRROUORAR
Date   Source Headline
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.